This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
In the ever-evolving landscape of pharmaceutical manufacturing, modular and automated platforms are spearheading a transformative shift, particularly in the realm of non-biologics. Apertus Pharmaceuticals and the API Innovation Center advanced lomustine production with continuous flow biomanufacturing solutions.
Global automation technology and software leader Emerson on April 16, 2024 introduced DeltaV Workflow Management, a next-generation software designed for life sciences companies in early-stage development. The post Software Streamlines Pharmaceutical Development appeared first on The Manufacturing Connection.
a Canadian integrated pharmaceutical Corporation, announces the acquisition of Dermolab Pharma Ltd., The closing of the transaction occurred after markets had closed on December 17, 2024. BOUCHERVILLE — LSL PHARMA GROUP INC., Steri-Med Pharma Inc. and Virage Sant Inc. Steri-Med Pharma Inc. and Virage Sant Inc.
SAN ANTONIO, 12 th August 2024 – Chromatography instruments and modular test equipment are revolutionising scientific analysis and industrial testing. By enabling precise separation and analysis of complex mixtures, chromatography plays a crucial role in ensuring pharmaceutical purity, food safety, and environmental compliance.
Aligning with Industry Trends: Healthnice Advances Step by Step Amid the global pharmaceutical industry’s evolution, high-end preparations have become a mainstream trend in drug development. Therefore, for pharmaceutical companies, high-end preparations represent a high-value, cost-effective strategy for differentiation.
The Coatings Ecosystem: Innovations Across Industries Sustainable Packaging Coatings: As countries combat carbon emissions, sustainable packaging coatings are becoming essential to reduce landfill waste, especially for industries like food, pharmaceuticals, and personal care.
today announced the appointment of Emma Harrington as the inaugural manufacturing site head for the company’s new mRNA vaccine manufacturing site in the Monash Technology Precinct in Melbourne, Australia, effective February 2024. Moderna, Inc.
October 1, 2024 – Frost & Sullivan assessed the laboratory information management systems (LIMS) industry and, based on its findings, recognizes LabVantage Solutions with the 2024 Global Company of the Year Award. SAN ANTONIO, TX. LabVantage LIMS is an enterprise platform serving the full product life cycle.
At Booth #W-16075, Pack-Smart will showcase its Delta-X Track and Trace solutions, designed to meet the growing demand for product authentication, regulatory compliance, and patient safety in the pharmaceutical supply chain.
San Antonio, TX — September 18, 2024 — Frost & Sullivan recently researched the real-world evidence analytics (RWE) solutions industry and, based on its findings, recognizes OM1 with the 2024 North American New Product Innovation Award.
Regulatory compliance across industries: Regulatory changes, including potential shifts in pro-EV policies and subsidies, will heavily influence consumer behavior and industry strategies. Strategic investments in AI and technology integration will empower companies to remain adaptable.
a Canadian specialty branded pharmaceutical company. This acquisition accelerates the company’s growth within the specialty branded pharmaceutical market. ” On May 24, 2024, Apotex entered its 50th year of business, marking an achievement rooted in pharmaceutical products. TORONTO — Apotex Inc.
billion in 2024, with significant growth in manufacturing and clean energy sectors. Abbott Laboratories : Specializing in pharmaceuticals and medical devices, Abbott plays a key role in healthcare manufacturing. While challenges persist in regaining pre-pandemic employment levels, recent developments point to a robust resurgence.
As of April 2023, the global pharmaceutical R&D pipeline has over 6000 molecules in active clinical development phase, showing a 5.8% growth from 2023 to 2024. increase from 2022. However, the pharma/biopharma industry overall shows stagnant R&D activity. Total R&D expenditure is approximately $276.81
Artificial intelligence (AI) is undeniably the technological force to reckon with in 2024. To unlock the full potential of AI, organizations must address these challenges head-on by dismantling data silos and prioritizing security/compliance across all IT systems. Hybrid cloud environments combine public and private resources.
Artificial intelligence (AI) is undeniably the technological force to reckon with in 2024. To unlock the full potential of AI, organizations must address these challenges head-on by dismantling data silos and prioritizing security/compliance across all IT systems. Hybrid cloud environments combine public and private resources.
Artificial intelligence (AI) is undeniably the technological force to reckon with in 2024. To unlock the full potential of AI, organizations must address these challenges head-on by dismantling data silos and prioritizing security/compliance across all IT systems. Hybrid cloud environments combine public and private resources.
Artificial intelligence (AI) is undeniably the technological force to reckon with in 2024. To unlock the full potential of AI, organizations must address these challenges head-on by dismantling data silos and prioritizing security/compliance across all IT systems. Hybrid cloud environments combine public and private resources.
July 9, 2024 – Frost & Sullivan recently assessed the integrated clinical trial optimization industry and, based on its findings, recognizes Clinion with the 2024 North American Technology Innovation Leadership Award. SAN ANTONIO, TX. The company is an innovator in the clinical trial and data management space.
a drug delivery company focused on the development and manufacturing of pharmaceutical films, was granted protection pursuant to an initial order issued under the Companies’ Creditors Arrangement Act by the Québec Superior Court. MONTREAL — IntelGenx Technologies Corp., The Initial Order appointed Ernst & Young Inc.
Effective March 15th, 2024, this certification enables HYTN to manufacture cannabis dried flower into bulk and finished GMP medical products. VANCOUVER — HYTN Innovations Inc.,
The announcement was made at AVEVA World 2024, taking place Oct. Pharmaceuticals : enhanced monitoring of manufacturing processes to ensure product quality, compliance and safety. 14-17 in Paris. Dianomic Systems is an exhibitor at the event, located in Booth 26.
The Drug, Chemical & Associated Technologies Association (DCAT) 2024 event held in New York City on March 18-21 showcased product and technology innovations and capabilities presentations by member companies. in January 2024 further enhanced its portfolio of complex drug-device combination products.
Healthcare and Pharmaceuticals. When it comes to healthcare and pharmaceuticals, cyberattacks can have particularly dire consequences. These audits should assess the third parties’ cybersecurity policies, procedures, infrastructure, and compliance with relevant regulations.
. – 2 December, 2024 – Frost & Sullivan researched the contract development and manufacturing organization industry and, based on its analysis, recognizes Bushu Pharmaceuticals (Pharma) with the 2024 APAC Customer Value Leadership Award.
The global proteomics industry is poised for significant expansion between 2024 and 2030, driven by advances in research and pharmaceutical applications. Click here to download The post The Future of Proteomics: Innovations, Challenges, and Industry Growth (2024-2030) appeared first on Frost & Sullivan.
a pharmaceutical company specializing in precision-based cannabinoids, announces that it has begun production on novel cannabis metered dose inhalers for the EU and the United Kingdom, made to global pharmaceutical standards and distributed by Blackpoint Limited, MediPharms exclusive sales and distribution partner in those territories.
CAPS joined the Ingersoll Rand family in 2024, expanding its access to the companys air, fluid, energy and medical technologies. Oil-free compressors The manufacturing, food and pharmaceutical sectors require a range of specialised Class Zero air quality compressors that meet standards according to ISO 8753-1:2010.
The number of robots ordered and their total value declined in the first nine months of 2024, according to the Association for Advancing Automation, or A3. From January through September 2024, North American businesses ordered 23,034 robots valued at $1.4 The dollar value of orders and shipments reportedly declined in 2024.
From prescription abandonment to uncompensated care, the issue ripples across patients, providers, pharmacies, and pharmaceutical companies. Safeguarding Trust: Privacy, Security, and Compliance Unmesh Lal: Handling sensitive data comes with responsibility. is affordabilityparticularly around access to medications.
Trump has also imposed tariffs on countries that import oil from Venezuela and he plans separate import taxes on pharmaceutical drugs, lumber, copper and computer chips. 2, as would products such as pharmaceutical drugs that he plans to tariff at a later date. Olu Sonola, head of U.S. The 10% rate would be collected starting Apr.
11 address to the Business Roundtable, a trade association of CEOs that during the 2024 campaign he wooed with the promise of lower corporate tax rates for domestic manufacturers. Trump was set to deliver a Mar.
We organize all of the trending information in your field so you don't have to. Join 45,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content